58 related articles for article (PubMed ID: 1792942)
1. Pamidronate reduces PTH-mediated bone loss in a gene transfer model of hyperparathyroidism in rats.
Mitlak BH; Rodda CP; Von Deck MD; Dobrolet NC; Neer RM; Nussbaum SR
J Bone Miner Res; 1991 Dec; 6(12):1317-21. PubMed ID: 1792942
[TBL] [Abstract][Full Text] [Related]
2. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats.
Mitlak BH; Schoenfeld D; Neer RM
J Bone Miner Res; 1994 Jan; 9(1):119-26. PubMed ID: 8154305
[TBL] [Abstract][Full Text] [Related]
3. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
5. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
Kawane T; Takahashi S; Saitoh H; Okamoto H; Kubodera N; Horiuchi N
Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069
[TBL] [Abstract][Full Text] [Related]
6. Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats.
Mitlak BH; Williams DC; Bryant HU; Paul DC; Neer RM
J Bone Miner Res; 1992 May; 7(5):479-84. PubMed ID: 1615756
[TBL] [Abstract][Full Text] [Related]
7. Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.
Rosen HN; Sullivan EK; Middlebrooks VL; Zeind AJ; Gundberg C; Dresner-Pollak R; Maitland LA; Hock JM; Moses AC; Greenspan SL
J Bone Miner Res; 1993 Oct; 8(10):1255-61. PubMed ID: 8256663
[TBL] [Abstract][Full Text] [Related]
8. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
[TBL] [Abstract][Full Text] [Related]
9. Dual-energy x-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss.
Griffin MG; Kimble R; Hopfer W; Pacifici R
J Bone Miner Res; 1993 Jul; 8(7):795-800. PubMed ID: 8352062
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats.
Kodama Y; Nakayama K; Fuse H; Fukumoto S; Kawahara H; Takahashi H; Kurokawa T; Sekiguchi C; Nakamura T; Matsumoto T
J Bone Miner Res; 1997 Jul; 12(7):1058-67. PubMed ID: 9200005
[TBL] [Abstract][Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone (1-34) increased total body bone mass in aged female rats.
Simmons HA; Pirie CM; Thompson DD; Ke HZ
J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878
[TBL] [Abstract][Full Text] [Related]
13. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
[TBL] [Abstract][Full Text] [Related]
14. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
15. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
[TBL] [Abstract][Full Text] [Related]
16. Site-specific effects of cerivastatin on bone in male Sprague-Dawley rats.
Banu J; Kalu DN
Bone; 2004 Mar; 34(3):432-42. PubMed ID: 15003791
[TBL] [Abstract][Full Text] [Related]
17. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
[TBL] [Abstract][Full Text] [Related]
18. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
Price RI; Gutteridge DH; Stuckey BG; Kent GN; Retallack RW; Prince RL; Bhagat CI; Johnston CA; Nicholson GC; Stewart GO
J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439
[TBL] [Abstract][Full Text] [Related]
19. In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study.
Karahan S; Kincaid SA; Lauten SD; Wright JC
Comp Med; 2002 Apr; 52(2):143-51. PubMed ID: 12022394
[TBL] [Abstract][Full Text] [Related]
20. Precise measurement of bone mineral density in rats using dual-energy X-ray absorptiometry.
Ladizesky MG; Zeni SN; Mautalén CA
Acta Physiol Pharmacol Ther Latinoam; 1994; 44(1-2):30-5. PubMed ID: 7640402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
